Products for Research Use Only
RegisterLogin

Regdanvimab

CAT: 0804-HY-P99346-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99346-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Regdanvimab (CT-P59) is a human monoclonal antibody that targets the receptor-binding domain of SARS-CoV-2 spike protein, blocking interaction with ACE2 for viral entry. Regdanvimab can be used for the research of COVID-19[1].
CAS Number
2444308-95-4
Product Name Alternative
CT-P59
UNSPSC
12352203
Target
Angiotensin-converting Enzyme (ACE) ; SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/regdanvimab.html
Purity
95.00
Solubility
H2O
Smiles
[Regdanvimab]
Molecular Weight
(146.22 kDa)
References & Citations
[1]Ryu DK, et al. The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2. Biochem Biophys Res Commun. 2021 Nov 12;578:91-96.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched

Alternative Products

CatalogName
abx831680-01Regdanvimab
GTR18337927-01Regdanvimab Antibody
E40YR1644Regdanvimab (CT-P59)
ICH5813-25mgRegdanvimab Biosimilar - Research Grade
047621Spike RBD (Regdanvimab) discontinued
GTR18780330-01(Regdanvimab) Biosimilar Reference Antibody
GTR18315709Spike RBD Reference Antibody (Regdanvimab)
F1014-5Anti-Spike RBD Antibody (Regdanvimab)
E24CVA013Anti-Spike RBD Reference Antibody (Regdanvimab)
RA0661-01Regdanvimab (Biosimilar Reference Antibody) (SARS-CoV-2 Spike RBD)

Popular Products